BridgeBio Pharma (BBIO) Current Taxes (2024 - 2025)
BridgeBio Pharma (BBIO) posted Current Taxes of $2.1 million for Q2 2025, up 82.13% sequentially from $1.2 million in Q4 2024.
BridgeBio Pharma (BBIO) Current Taxes (2024 - 2025) Analysis & Trends
BridgeBio Pharma has reported Current Taxes for 2 years, with the latest figure at $2.1 million in Q2 2025.
- Quarterly Current Taxes changed N/A year-over-year to $2.1 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.1 million (changed N/A YoY) and the FY2024 annual result came in at $1.2 million, changed N/A from the prior year.
- Current Taxes climbed to $2.1 million in Q2 2025 per BBIO's latest filing, from $1.2 million in the prior quarter.
- Over five years, Current Taxes peaked at $2.1 million in Q2 2025 and troughed at $1.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | BridgeBio Pharma | 15.60 Bn | 14.89 Bn | 228.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.15 Mn |